Full-Time

Director – Global Analytical Sciences and Technology

Asat, Drug Substance

Confirmed live in the last 24 hours

Vaxcyte

Vaxcyte

201-500 employees

Develops vaccines for bacterial infections

Biotechnology
Healthcare

Compensation Overview

$220k - $236kAnnually

Senior, Expert

Remote in USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis

You match the following Vaxcyte's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Degree(s) in Chemical or Biochemical Engineering, Chemistry, Biochemistry, or related discipline with a minimum of 12+ years of relevant experience for Ph.D., 15+ years for M.S./M.A., or 20+ years for B.S./B.A.
  • Extensive experience in analytical method development, validation, method transfer, commercial launch, and analytical lifecycle management of glycoconjugate vaccines preferred.
  • Demonstrated ability to coordinate CDMO activities and direct experience with directing outsourced assay development, stability, and quality control in support of CMC activities.
  • Leadership experience in analytical development, QC, ASAT or MSAT in supervisory and/or matrixed team roles.
  • Able to leverage deep technical knowledge in a collaborative manner to establish strategic plans and achieve collective goals.
  • Excellent organization, problem solving and strategic planning skills.
  • Highly skilled in both verbal and written communication with the ability to interact effectively with people of diverse backgrounds and perspectives.
  • Proactively recognizes needs and potential challenges and directs activities to implement effective solutions.
  • The ability to seek and analyze data from a variety of sources to support decisions and to align others with the organization's overall strategy.
  • An entrepreneurial and creative approach to developing new, innovative ideas that will stretch the organization and push the boundaries within the industry.
Responsibilities
  • Provide technical and scientific advice for internal and external stakeholders in support of the successful execution of launch plans and post-launch commercial activities.
  • Manage and support the analytical control strategy with advanced state-of-the-art analytical equipment and technologies and routine trouble shooting.
  • Develop and validate new analytical techniques and methods.
  • Provide leadership for analytical validation and comparability activities.
  • Provide analytical support activities related to method development and qualification/validation, product characterization, and comparability assessment for multiple programs.
  • Provide technical support for complex analytical challenges.
  • Tech-transfer new technologies - support technical transfers and integration of new technologies.
  • Support of our internal and external manufacturing network, including materials management and data analytics.
  • Engage in technical reviewing and authoring of regulatory filings and responding to questions received from health authorities.
  • Serve as a thought partner with Regulatory, CMC, Quality, Supply Chain, Sourcing, and Process Engineering colleagues.
  • Collaboration with cross-functional teams across the internal and external network to drive the successful development and commercial launch of pipeline products.
  • Effectively and efficiently communicate process performance to key stakeholders (internal-facing and external-facing).
  • Contribute as Global ASAT lead and as member of the Global Manufacturing Operations, with an aim to ensure effective and efficient delivery of our life-enhancing therapies to our patients.
  • Lead matrixed teams focused on analytical lifecycle of test methods for commercialization with an aim to ensure effective and efficient delivery of our life-enhancing therapies to our patients.
Desired Qualifications
  • Extensive experience in analytical method development, validation, method transfer, commercial launch, and analytical lifecycle management of glycoconjugate vaccines preferred.

Vaxcyte develops vaccines aimed at preventing bacterial infections, focusing on diseases like invasive pneumococcal disease, Group A Strep, periodontitis, and Shigella. Their lead product, VAX-24, is a pneumococcal conjugate vaccine that targets 24 strains of the Streptococcus pneumoniae bacteria and has received Breakthrough Therapy designation from the FDA. Vaxcyte utilizes advanced chemistry and a proprietary cell-free protein synthesis platform, XpressCF™, to create vaccines that can effectively address the complex defenses of bacteria while stimulating an immune response. Unlike traditional cell-based methods, their approach allows for the development of broad-spectrum vaccines. Vaxcyte's goal is to provide effective vaccines that can significantly reduce the impact of bacterial diseases on global health.

Company Stage

IPO

Total Funding

$273.3M

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for VAX-24 may accelerate its market entry.
  • Global pneumococcal vaccines market is projected to grow at a CAGR of 5.6% until 2030.
  • Recent $1.5 billion public offering strengthens Vaxcyte's financial position for future developments.

What critics are saying

  • Competition from mRNA technology developers like Moderna and BioNTech is intense.
  • Potential regulatory delays could impact Vaxcyte's clinical trial timelines.
  • Intellectual property disputes may arise over cell-free protein synthesis technology.

What makes Vaxcyte unique

  • Vaxcyte uses a proprietary cell-free protein synthesis platform, XpressCF™, for vaccine development.
  • Their lead product, VAX-24, targets 24 strains of Streptococcus pneumoniae bacteria.
  • Vaxcyte focuses on broad-spectrum vaccines for bacterial infections, unlike traditional methods.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Stock Options

Remote Work Options